Tag: research

Univo IRB
United States

Julie Blasingim Promoted to Chief Executive Officer of Univo IRB

RALEIGH, N.C. – Univo IRB, a next generation institutional review board (IRB) backed by QHP Capital, today announced Julie Blasingim has been promoted to CEO by Univo’s board of directors. As CEO, Blasingim will drive Univo IRB’s strategic growth and innovation, bringing a modern iteration of IRB solutions to unify patients and research, and support today’s clinical trials. Julie Blasingim will lead @UnivoIRB through its next chapter … Continue reading Julie Blasingim Promoted to Chief Executive Officer of Univo IRB

Impact Newswire
VAST
United States

Space Executive Clay Mowry Joins Vast as Advisor

LONG BEACH, Calif.–(BUSINESS WIRE)–Vast, a pioneer in space habitation technologies, announces the appointment of Clay Mowry as its newest Advisor. “I am excited to join Vast as an Advisor and contribute to the company’s mission of advancing commercial space stations”Post this Mowry’s career spans over two decades in the commercial launch, satellite, and space station sectors. As President of the International Astronautical Federation (IAF), Mowry … Continue reading Space Executive Clay Mowry Joins Vast as Advisor

Impact Newswire
BioConsortia
United States

BioConsortia secures $15 million in latest funding round

Funding global pipeline development of transformational nitrogen-fixing and nematicidal seed treatment products, and extending BioConsortia’s gene-editing leadership position April 01, 2024 10:12 AM Eastern Daylight Time DAVIS, Calif.–(BUSINESS WIRE)–BioConsortia, Inc., a leading agricultural technology company that discovers, designs and licenses advanced microbial products to reduce the ecological impacts of agriculture while ensuring crop productivity, today announced that the Company has closed an internal financing round … Continue reading BioConsortia secures $15 million in latest funding round

Impact Newswire
Gilead Sciences
United States

Gilead Sciences Announces Completion of Acquisition of CymaBay

Acquisition Reinforces Gilead’s Leadership in Developing Innovative Therapies For Challenging Liver Diseases March 22, 2024 09:18 AM Eastern Daylight Time FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction to acquire CymaBay Therapeutics, Inc. (Nasdaq: CBAY) for approximately $4.3 billion in total equity value. The addition of CymaBay’s investigational lead product candidate, seladelpar for the treatment of … Continue reading Gilead Sciences Announces Completion of Acquisition of CymaBay

Impact Newswire
A2 Bio
United States

A2 Bio Appoints James Robinson as New Chief Executive Officer and Member of the Board of Directors

Robinson to Lead Next Phase of Company’s Expansion and Pipeline Advancement March 25, 2024 09:00 AM Eastern Daylight Time AGOURA HILLS, Calif.–(BUSINESS WIRE)–A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to address the high unmet needs in cancer, today announced the appointment of James Robinson as its Chief Executive Officer and a member of its Board of Directors, … Continue reading A2 Bio Appoints James Robinson as New Chief Executive Officer and Member of the Board of Directors

Impact Newswire